YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
NCT ID: NCT00048659
Last Updated: 2012-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
INTERVENTIONAL
2004-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer
NCT00050297
Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer
NCT01591122
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005847
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
NCT00887198
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
NCT01946204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
YM598
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astellas Pharma US, Inc.
INDUSTRY
Astellas Pharma Inc
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alaska Clinical Research Center, LLC
Anchorage, Alaska, United States
San Bernardino Urological Associates
San Bernardino, California, United States
Western Clinical Research, Inc.
Torrance, California, United States
Shands Hospital
Gainesville, Florida, United States
Sylvester Comprehensive Cancer Center
Miami, Florida, United States
Georgia Urology,PA Research Institute
Atlanta, Georgia, United States
University of Chicago, Section of Hematology/Oncology
Chicago, Illinois, United States
University of Illinois, Department of Urology
Chicago, Illinois, United States
Michiana Hematology/Oncology
South Bend, Indiana, United States
The Urologic Institute of New Orleans
Gretna, Louisiana, United States
Henry Ford Hospital
Detroit, Michigan, United States
Washington University School of Medicine
St Louis, Missouri, United States
Memphis Cancer Center
Memphis, Tennessee, United States
Virginia Mason Medical Center
Seattle, Washington, United States
Department of Medical Oncology, The Canberra Hospital
Canberra, , Australia
Department of Medical Oncology, Concord Hospital Medical Centre
Concord, , Australia
Division of Oncology Ward, Royal Brisbane Hospital
Herston, , Australia
Department of Clinical Oncology, Royal North Shore Hospital
St Leonards, , Australia
Cancer Care Centre, St. George Hospital
Sydney, , Australia
Department of Medical Oncology, Newcastle Mater Hospital
Waratah, , Australia
Southern Medical Day Care Centre
Wollongong, , Australia
Queen Elizabeth Hospital, Clinical Hematology & Oncology
Woodville, , Australia
Cliniques Universitaires St-Luc, Service d'Urologie
Brussels, , Belgium
Centre Hospitalier Notre Dame et Reine Fabiola, Service d'oncologie
Charleroi, , Belgium
Centre Paul Papin
Angers, , France
Service d'Urologie, Hôpital Henri Mondor
Créteil, , France
Pavillon V, Service d'Urologie et de transplatation, Hôpital Edouard Herriot
Lyon, , France
Service d' Urologie CHU, Hopital Bichat
Paris, , France
Krankenhause am Urban, Urologie Dieffenfachstr
Berlin, , Germany
Dept Urology University of Essen
Essen, , Germany
Urologische Klinik der MHH
Hanover, , Germany
Klinikum Mannheim Urology
Mannheim, , Germany
Mater Misericordiae Hospital
Dublin, , Ireland
Universitair Medisch Centrum Utrecht, Dienst Medische Oncologie
Utrecht, , Netherlands
Kilinika Chemioterapii, Centrum Onkologii Instytut im M sklodowskiej Curie
Krakow, , Poland
Oddzial Chemioterapii
Krakow, , Poland
Klinika Chemioterapii AM
Lodz, , Poland
Samodzielny Publiczny Zaklad Opieki zdrowotnej, Wojewodzki Osrodek Onkologii
Opole, , Poland
Szpital Wojewodzki im Sw Lukasza SP ZOZ Tarnow
Tarnów, , Poland
Klinika Nowotworow Ukladu
Warsaw, , Poland
Szpital CSK WAMl, Klinika Okologii
Warsaw, , Poland
Hospital Clinic i Provincial, Servicio de Oncologia
Barcelona, , Spain
Hospital General Vall d'Hebron, Servicio de Oncología
Barcelona, , Spain
Hospital Universitario de Getafe, Servicio de Urologia, Crta
Getafe (Madrid), , Spain
Hospital Universitario Príncipe de Asturias, Servicio de Urología
Madrid, , Spain
Instituto Valenciano de Oncologia, Servicio de Oncologia
Valencia, , Spain
Department of Urological Research, Derriford Hospital
Devon, , United Kingdom
Clinical Research Centre, St George's Hospital, Urology Division
London, , United Kingdom
Department of Urology, St Bartholomew's Hospital
London, , United Kingdom
Imperial College School of Medicine, Dept Cancer Medicine
London, , United Kingdom
Department of Urology, East Surrey Hospital
Surrey, , United Kingdom
Royal Surrey County Hospital
Surrey, , United Kingdom
St Richard's Hospital
West Sussex, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
598-CL-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.